Who we are
Founded by experts in neuroscience, clinical psychology, and pharmacology, we bring over 20 years of experience in CNS drug development and regulatory science. Our team has contributed to early-phase clinical programs, regulatory workshops, and international working groups shaping how abuse potential, physical dependence, and cognitive outcomes are evaluated.
Our Mission
We seek to make the complex effects of CNS-active drugs measurable, reliable, and actionable.
We combine rigorous scientific validation with practical implementation. Each measure we develop is designed to withstand regulatory scrutiny while remaining feasible in real-world clinical trials.